Pyxis Oncology Inc (PYXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PYXS | SRZN | GALT | ||
| Company | Pyxis Oncology Inc | Consonance-Hfw Acq Corp | Galectin Therapeutic | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 3.32 | 23.75 | 4.14 | ||
| High | 3.38 | 23.75 | 4.20 | ||
| Low | 3.22 | 22.36 | 4.01 | ||
| Last | 3.27 | 22.68 | 4.12 | ||
| Change | -0.05 | -1.33 | -0.02 | ||
| Percent Change | -1.51% | -5.54% | -0.48% | ||
| Volume | 47,536 | 30,715 | 29,872 | ||
| 20-Day Average Volume | 1,403,252 | 210,441 | 337,601 | ||
| Previous | 3.32 | 24.01 | 4.14 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 3.21 | 23.59 | 3.52 | ||
| 20-Day Raw Stochastic | 64.99% | 27.47% | 81.50% | ||
| 20-Day Relative Strength | 55.39 | 46.53 | 59.41 | ||
| Weighted Alpha | +73.62 | +46.55 | -22.26 | ||
| Today's Opinion | 96% Buy | 56% Sell | 72% Buy | ||
| Yesterday's Opinion | 96% Buy | 8% Sell | 56% Buy | ||
| Last Month's Opinion | 72% Buy | 72% Sell | 16% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.00% since 08/21/26 | -6.04% since 08/21/26 | +12.23% since 08/21/26 | ||
| Low | 2.83 on 08/24/26 | 22.36 on 08/28/26 | 3.58 on 08/24/26 | ||
| High | 3.38 on 08/28/26 | 25.01 on 08/25/26 | 4.45 on 08/27/26 | ||
| 1-Month | |||||
| %Chg | +12.19% since 07/28/26 | +16.19% since 07/28/26 | +21.83% since 07/28/26 | ||
| Low | 1.90 on 08/11/26 | 18.12 on 07/29/26 | 2.72 on 08/04/26 | ||
| High | 4.00 on 08/11/26 | 27.32 on 08/07/26 | 4.45 on 08/27/26 | ||
| 3-Month | |||||
| %Chg | +83.42% since 05/28/26 | -13.84% since 05/28/26 | +60.70% since 05/28/26 | ||
| Low | 1.54 on 06/11/26 | 18.12 on 07/29/26 | 2.26 on 06/05/26 | ||
| High | 4.00 on 08/11/26 | 27.32 on 08/07/26 | 5.55 on 07/14/26 | ||
| 6-Month | |||||
| %Chg | +122.10% since 02/27/26 | -18.92% since 02/27/26 | +38.59% since 02/27/26 | ||
| Low | 1.26 on 03/30/26 | 18.12 on 07/29/26 | 2.03 on 05/07/26 | ||
| High | 4.00 on 08/11/26 | 35.00 on 05/07/26 | 5.55 on 07/14/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 276,915 | 278,756 | 272,648 | ||
| Shares Outstanding, K | 83,408 | 11,610 | 65,857 | ||
| Annual Sales, $M | 13,860,000 | 3,480,000 | 0 | ||
| Annual Net Income, $M | -79,620,000 | -242,030,000 | -30,840,000 | ||
| Last Qtr Sales, $M | 0 | 5,000,000 | 0 | ||
| Last Qtr Income, $M | -23,270,000 | 50,180,000 | -9,110,000 | ||
| 60-Month Beta | 1.31 | 0.52 | 0.41 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.40 on 08/13/26 | -0.41 on 08/06/26 | -0.14 on 08/14/26 | ||
| Latest Earnings Date | 11/02/26 | 11/06/26 | 11/13/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividend Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||